Invasive treatment performed for acute myocardial infarction in a patient with immune thrombocytopenic purpura
| Autor: | Luis J. Placer Peralta, José Antonio Diarte de Miguel, Juan Sánchez-Rubio Lezcano, Isabel Calvo Cebollero, Maria Cruz Ferrer Gracia, Gabriel Galache Osuna |
|---|---|
| Rok vydání: | 2008 |
| Předmět: |
medicine.medical_specialty
Percutaneous business.industry medicine.medical_treatment Heparin medicine.disease Clopidogrel Asymptomatic Thrombocytopenic purpura Surgery immune system diseases hemic and lymphatic diseases Angioplasty Medicine cardiovascular diseases Myocardial infarction Myocardial infarction diagnosis medicine.symptom Cardiology and Cardiovascular Medicine business medicine.drug |
| Zdroj: | International Journal of Cardiology. 127:e183-e185 |
| ISSN: | 0167-5273 |
| DOI: | 10.1016/j.ijcard.2007.05.075 |
| Popis: | Acute myocardial infarction (AMI) is infrequent in patients with idiopathic thrombocytopenic purpura (ITP) so the best treatment is not well known. The next case shows a 37-year-old man with chronic ITP who suffered an anterior AMI, the platelet count at admission was 39,000 microL. He was treated successfully with primary percutaneous angioplasty under anticoagulation with unfractionated heparin and antiaggregation with clopidogrel and ASA. At the end of the procedure we sealed the femoral access site with Angio-Seal(R). He didn t have any complications during the procedure and after six months remained asymptomatic. In some patients with chronic ITP and AMI the percutaneous treatment could be a good option. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect